CINRE s.r.o.

At CINRE s.r.o. in Petrzalka, the clinical trial activity focuses on cardiovascular diseases, with studies centered on major conditions such as acute ischemic stroke, transient ischemic attack, acute myocardial infarction, and hypertension. The research is designed to evaluate new treatments and improve protection against serious heart and blood vessel events.

• Testing therapies aimed at lowering the risk of ischemic stroke and related neurological complications
• Evaluating emergency treatment approaches for suspected acute myocardial infarction
• Studying better ways to control high blood pressure in people with elevated cardiovascular risk

These trials reflect a strong interest in preventing first and repeat events in patients with established cardiovascular disease and other high-risk conditions.

The site is also involved in research on rapid-response care for stroke and acute coronary syndromes, with the goal of improving outcomes when symptoms appear suddenly. This line of research examines whether new therapies can reduce the chance of disabling complications after a suspected vascular emergency.

• Assessing treatment options for patients after acute ischemic stroke or high-risk transient ischemic attack
• Exploring self-administered therapy for people at risk of recurrent acute myocardial infarction
• Supporting faster intervention in time-sensitive cardiovascular events

This work is especially relevant for patients who need timely protection against repeat events and long-term disability.

Another key area of investigation at this hospital clinic is the management of atherosclerotic cardiovascular disease alongside chronic kidney disease and systemic inflammation. These studies aim to determine whether new therapies can better reduce major cardiovascular complications in people with complex, overlapping risk factors.

• Evaluating treatments for established cardiovascular disease with additional inflammatory burden
• Studying patients with chronic kidney disease who face higher rates of heart and vessel complications
• Measuring whether new approaches can lower the risk of major adverse cardiovascular events

The research helps address the needs of patients whose heart disease is made more difficult by kidney problems and persistent inflammation.

Clinical trials at this site also examine better ways to manage hypertension in people with established cardiovascular disease or a strong likelihood of developing it. The purpose of this research is to test whether newer treatment strategies can improve blood pressure control and reduce the chance of future heart, stroke, or heart failure events.

• Investigating therapies for blood pressure that is not adequately controlled
• Reducing the risk of cardiovascular death, stroke, and heart failure events
• Supporting prevention in patients with high cardiovascular risk

Overall, the research portfolio at Kardiologicka ambulancia is centered on prevention, risk reduction, and improved treatment effectiveness across major cardiovascular conditions.